Methods and compositions using
Provided herein are prime-boost regimens and materials used therein. The prime-boost regimens enhance the immune response to a target antigen. The vaccines used for boost are comprised of recombinant attenuated metabolically active Listeria that encodes an expressible antigen that is cross-reactive with the target antigen. In some examples, the immune response is a cellular immune response.
1. A method for enhancing an immune response in a mammal to mesothelin, comprising:
administering to the mammal an effective amount of a boost dose of a vaccine comprising an attenuated Listeria that encodes an expressible, immunologically active portion of mesothelin, wherein the mammal previously had been administered an effective amount of a prime dose of an inactivated tumor cell containing a nucleic acid that encodes mouse granulocyte macrophage-colony stimulation factor (GM-CSF).
2. The method of claim 1 wherein the attenuated Listeria comprises a mutation that inactivates ActA, InlB, or both ActA and InlB.
3. The method of claim 1 wherein the attenuated Listeria is ΔactAΔinlB.
4. The method of claim 1 wherein the attenuated Listeria is killed but metabolically active (“KBMA”).